pharma-iq.com rank 69 |
Number of domains linking to pharma-iq.com 3 | semantic flow 0.53 |
Number of links to pharma-iq.com 10 | semantic flow 0.53 |
Number of domains linked from pharma-iq.com 75 | semantic flow 7.52 |
Number of links from pharma-iq.com 112 | semantic flow 7.52 |
Pages with highest topical PageRank pointing to domain.
On-topic pages from domain with highest topical PageRank.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
Biomanufacturing: Intercompatibility with single use system devices | Pharmaceuticals & Biotechnology | Pharma & Biotech Resources https://www.pharma-iq.com/manufacturing/videos/biomanufacturing-intercompatibility-with-si | 0.28 | 0.92 | 42 | 19 | 2 | 2 | 0 | 0 | |
| Pharmaceuticals & Biotechnology | Pharma & Biotech Resources https://www.pharma-iq.com/all/business-development/whitepapers | 0.28 | 0.99 | 65 | 29 | 2 | 2 | 0 | 0 | |
Patient Centricity: Why customer experience strategies should still be a priority | Pharmaceuticals & Biotechnology | Pharma & Biotech https://www.pharma-iq.com/business-development/patient-centricity-why-customer-experience | 0.28 | 0.94 | 66 | 32 | 4 | 3 | 0 | 0 | |
| Pharmaceuticals & Biotechnology | Pharma & Biotech Resources https://www.pharma-iq.com/all/pre-clinical-discovery-and-development/whitepapers | 0.28 | 0.98 | 63 | 29 | 2 | 2 | 0 | 0 | |
| Pharmaceuticals & Biotechnology | Pharma & Biotech Resources https://www.pharma-iq.com/all/medical-devices-and-diagnostics/whitepapers | 0.28 | 0.99 | 69 | 36 | 2 | 2 | 0 | 0 | |
UDIs for Medical Devices: Lessons Learnt from Cook Medical | Pharmaceuticals & Biotechnology | Pharma & Biotech Resources https://www.pharma-iq.com/medical-devices-and-diagnostics/white-papers/udis-medical-device | 0.28 | 0.97 | 48 | 22 | 2 | 2 | 0 | 0 | |
Medical Device UDIs: What You Need to Know | Pharmaceuticals & Biotechnology | Pharma & Biotech Resources https://www.pharma-iq.com/regulatorylegal/columns/medical-device-udis-what-you-need-to-kno | 0.28 | 0.96 | 62 | 26 | 2 | 2 | 0 | 0 | |
Hi Folks, I have a basic question. If I am using a contract manufacturing organization to produce my company's first drug product, who is https://www.pharma-iq.com/questions/hi-folks-i-have-basic-question-if-i-am-using-contract- | 0.28 | 0.69 | 42 | 20 | 2 | 2 | 0 | 0 | |
The Case of The Brexit Chain Reaction | Pharmaceuticals & Biotechnology | Pharma & Biotech Resources https://www.pharma-iq.com/market-access/articles/the-case-of-the-brexit-chain-reaction | 0.21 | 0.94 | 61 | 25 | 2 | 2 | 0 | 0 | |
Drug Regulatory Affairs | Pharmaceuticals & Biotechnology | Pharma & Biotech Resources https://www.pharma-iq.com/glossary/drug-regulatory-affairs | 0.21 | 0.99 | 61 | 35 | 3 | 2 | 0 | 0 |
On-topic pages from domain with highest topical PageRank having a few outgoing links and domains.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
FDA guidance for Medical 3D Printing https://www.pharma-iq.com/news/fda-releases-new-guidance-on-3d-printed-medical | 0.19 | 0.8 | 57 | 27 | 7 | 4 | 0 | 0 | |
The Best Clinical Research Companies https://www.pharma-iq.com/regulatorylegal/articles/top-10-clinical-research-organisations- | 0.19 | 0.98 | 78 | 37 | 8 | 7 | 0 | 0 | |
Industry Forecast: 2017 Trends | Pharmaceuticals & Biotechnology | Pharma & Biotech Resources https://www.pharma-iq.com/market-access/articles/industry-forecast-2017-trends | 0.19 | 0.89 | 67 | 29 | 7 | 7 | 0 | 0 | |
Artificial Intelligence In Big Pharma https://www.pharma-iq.com/informatics/articles/is-big-pharma-really-on-cusp-of-ai-shake-ou | 0.18 | 0.97 | 74 | 37 | 8 | 8 | 0 | 0 |
Relevant domains with most links to selected domain.
domain | |||
---|---|---|---|
http://bioplanassociates.com/ | 8 | 0.46 | bioplanassociates.com |
http://biopharminternational.com/ | 1 | 0.04 | biopharminternational.com |
http://pharmalogisticsiq.com/ | 1 | 0.03 | pharmalogisticsiq.com |
Relevant domains with most links from selected domain.
Pages from domain with most relevant inbound links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://www.pharma-iq.com/market-access/articles/pharmas-missing-ingredient-in-its-outcome | 2 | 0.16 | 0.98 | 0.14 | 0.68 | yes | 65 | 25 | 2 | 2 | 0 | 0 | |
https://www.pharma-iq.com/clinical/articles/how-wearables-are-transforming-clinical-trials | 2 | 0.16 | 0.96 | 0.14 | 0.83 | yes | 69 | 31 | 2 | 2 | 0 | 0 | |
https://www.pharma-iq.com/clinical | 1 | 0.15 | 0.98 | 0.07 | 0.97 | yes | 62 | 32 | 3 | 2 | 0 | 0 | |
https://www.pharma-iq.com/news/biotech-in-the-uk-enjoys-rapid-growth | 1 | 0.15 | 0.97 | 0.07 | 0.99 | yes | 60 | 31 | 8 | 6 | 0 | 0 | |
https://www.pharma-iq.com/news/5-global-risks-ahead-for-2018 | 1 | 0.15 | 0.97 | 0.07 | 0.72 | yes | 55 | 24 | 3 | 2 | 0 | 0 | |
https://www.pharma-iq.com/cookie-policy | 1 | 0.15 | 0.98 | 0.07 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.pharma-iq.com/market-access/articles/three-survival-tips-for-pharma-firms-faci | 1 | 0.15 | 0.98 | 0.07 | 0.97 | yes | 65 | 28 | 6 | 6 | 0 | 0 | |
https://www.pharma-iq.com/about-us | 1 | 0.15 | 0.99 | 0.07 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.pharma-iq.com/informatics/articles/medical-artificial-intelligence | 1 | 0.15 | 0.93 | 0.07 | 0.82 | yes | 64 | 28 | 2 | 2 | 0 | 0 | |
https://www.pharma-iq.com/market-access/articles/where%E2%80%99s-the-relief-from-drug-pric | 1 | 0.15 | 0.94 | 0.06 | 0.95 | yes | 77 | 36 | 11 | 10 | 0 | 0 |
Pages from domain with most likely on-topic outgoing links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://www.pharma-iq.com/ | 43 | 0.15 | 0.97 | 2.93 | 1 | yes | 85 | 44 | 8 | 3 | 0 | 0 | |
https://www.pharma-iq.com/market-access/articles/where%E2%80%99s-the-relief-from-drug-pric | 11 | 0.15 | 0.94 | 0.68 | 0.95 | yes | 77 | 36 | 11 | 10 | 0 | 0 | |
https://www.pharma-iq.com/news/biotech-in-the-uk-enjoys-rapid-growth | 10 | 0.15 | 0.97 | 0.73 | 0.99 | yes | 60 | 31 | 8 | 6 | 0 | 0 | |
https://www.pharma-iq.com/clinical | 9 | 0.15 | 0.98 | 0.59 | 0.97 | yes | 62 | 32 | 3 | 2 | 0 | 0 | |
https://www.pharma-iq.com/informatics/articles/medical-artificial-intelligence | 5 | 0.15 | 0.93 | 0.18 | 0.82 | yes | 64 | 28 | 2 | 2 | 0 | 0 | |
https://www.pharma-iq.com/market-access/articles/pharmas-missing-ingredient-in-its-outcome | 5 | 0.16 | 0.98 | 0.15 | 0.68 | yes | 65 | 25 | 2 | 2 | 0 | 0 | |
https://www.pharma-iq.com/market-access/articles/three-survival-tips-for-pharma-firms-faci | 4 | 0.15 | 0.98 | 0.26 | 0.97 | yes | 65 | 28 | 6 | 6 | 0 | 0 | |
https://www.pharma-iq.com/pre-clinical-discovery-and-development/white-papers/the-future-o | 4 | 0.16 | 0.96 | 0.24 | 0.89 | yes | 54 | 28 | 7 | 7 | 0 | 0 | |
https://www.pharma-iq.com/clinical/articles/how-wearables-are-transforming-clinical-trials | 3 | 0.16 | 0.96 | 0.12 | 0.83 | yes | 69 | 31 | 2 | 2 | 0 | 0 | |
https://www.pharma-iq.com/cookie-policy | 1 | 0.15 | 0.98 | 0 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 |
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.